Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Oruka Therapeutics (ORKA) Long-Term Debt Issuances (2024)

Oruka Therapeutics' quarterly Long-Term Debt Issuances came in at $25.0 million in Q1 2024.

Oruka Therapeutics has reported Long-Term Debt Issuances for 1 years, with the latest figure at $25.0 million in Q1 2024.

  • For the quarter ending Q1 2024, Long-Term Debt Issuances changed N/A year-over-year to $25.0 million; the trailing twelve-month figure through Dec 2024 stood at $25.0 million (changed N/A YoY), and the FY2024 full-year result was $25.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q1 2024 stood at $25.0 million.
  • The five-year high for Long-Term Debt Issuances was $25.0 million in Q1 2024, with the low at $25.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.73 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 24.98 Mn
Mar 31, 2024 24.98 Mn